Webinar Date/Time: Tue, Dec 5, 2023 11:00 AM EST
Carrier-based formulations are designed to take very small particles into the lungs via inhalation. How can jet milling be used to help create successful carrier-based inhaled drugs?
Register Free: https://www.pharmtech.com/pt_w/manufacturing-inhaled-particles
Event Overview:
Carrier-based formulations for dry powder inhalers are precisely designed to transport extremely small particles (1-5 µm) into the lungs. When developing a carrier-based formulation, jet milling can be used to micronize these particles. High or low shear mixing processes can both be applied to formulate mixtures capable of carrying the fine API particles into the deep lung.
During this webcast, the following questions will be addressed:
Key Learning Objectives:
Who Should Attend:
Speakers:
Beatriz Noriega Fernandes, PhD
Senior Principal Scientist
Lonza
Dr Beatriz Noriega Fernandes is a Senior Principal Scientist in the R&D group at Lonza’s site in Monteggio, Switzerland. She leads a portfolio of programs and identifies potential strategies for dry powder inhalation delivery of small molecule APIs. She is a Biological Engineer by training, with a PhD in Pharmaceutical Technology from the University of Lisbon, Portugal. Her background includes more than 7 years of experience in in the pharmaceutical industry, in various areas of dry powder inhaler development. Her areas of expertise include the formulation and manufacture of inhalable clinical products ranging from low to high dose, from laboratory to industrial scales.
Ilaria Valente
Technical Sales Manager
Lonza
Ilaria Valente is technical sales manager at Lonza, specializing in the micronization of small molecule APIs. With a commercial background, she holds a bachelor’s degree in Foreign Languages for Communication and Business from the Catholic University of Milan. She started her career in sales, progressed through account management and business development roles, and then in 2018 moved to the drug substance technical sales team. With a decade of experience in the micronization business, her role has recently expanded to include integrated offer services. In her role, she is responsible for the evaluation of requests from customers, calculating costs for services and production scenarios, and supporting the sales organization in writing micronization and integrated services proposals. Ilaria is also responsible for coordinating the technical team during the evaluation process.
Register Free: https://www.pharmtech.com/pt_w/manufacturing-inhaled-particles
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.